This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010; 62:600-10.10.1002/acr.20140Wolfe FClauwDJFitzcharlesMAGoldenbergDLKatzRSMease Pet alThe American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severityArthritis Care Res20106260010Open DOISearch in Google Scholar
Bernard AL, Prince A, Edsall P. Quality of life issues for fibromyalgia patients. Arthritis Care Res. 2000; 13: 42-50.10.1002/1529-0131(200002)13:1<42::AID-ART7>3.0.CO;2-R11094925BernardALPrince AEdsallP.Quality of life issues for fibromyalgia patientsArthritis Care Res2000134250Open DOISearch in Google Scholar
Couto CI, Natour J, Carvalho AB. Fibromyalgia: its prevalence and impact on the quality of life on a hemodialyzed population. Hemodial Int. 2008; 12: 66-72.1827184410.1111/j.1542-4758.2008.00243.xCoutoCINatour JCarvalho AB. Fibromyalgia: its prevalence and impact on the quality of life on a hemodialyzed populationHemodial Int2008126672Search in Google Scholar
Assumpção A, Pagano T, Matsutani LA, Ferreira EAG. Pereira CAB, Marques AP. Quality of life and discriminating power of two questionnaires in fibromyalgia patients: fibromyalgia impact questionnaire and medical outcomes study 36-item short-form health survey. Rev Bras Fisioter. 2010; 14: 284-9.10.1590/S1413-3555201000500001520949228Assumpção APagano TMatsutaniLAFerreiraEAGPereiraCABMarquesAPQuality of life and discriminating power of two questionnaires in fibromyalgia patients: fibromyalgia impact questionnaire and medical outcomes study 36-item short-form health surveyRev Bras Fisioter2010142849Open DOISearch in Google Scholar
Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2007; 62:115-26.1803933010.1111/j.1742-1241.2007.01638.xHoffmanDLDukesEMThe health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12Int J Clin Pract20076211526Search in Google Scholar
Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheum. 2005; 32:5-21.MeaseP.Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatmentJ Rheum200532521Search in Google Scholar
Recla JM. New and emerging therapeutic agents for the treatment of fibromyalgia: an update. J Pain Res. 2010; 3:89-103.21197313ReclaJMNew and emerging therapeutic agents for the treatment of fibromyalgia: an updateJ Pain Res201038910310.2147/JPR.S6792Search in Google Scholar
Arnold LM. Biology and therapy of fibromyalgia: New therapies in fibromyalgia. Arthritis Res Ther. 2006; 8:212.1676204410.1186/ar1971ArnoldLMBiology and therapy of fibromyalgia: New therapies in fibromyalgiaArthritis Res Ther20068212Search in Google Scholar
Häuser W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain. 2010; 11:505-21.10.1016/j.jpain.2010.01.00220418173Häuser WPetzke FSommerCComparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndromeJ Pain20101150521Open DOISearch in Google Scholar
Bonnet F. [Mechanism of the analgesic effect of alpha 2 adrenergic agonists]. Cah Anesthesiol. 1994; 42:723-5. (in French)BonnetF[Mechanism of the analgesic effect of alpha 2 adrenergic agonists]Cah Anesthesiol1994427235Search in Google Scholar
Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet. 2000; 355: 911-8.10.1016/S0140-6736(99)11381-310752718KentJMSNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depressionLancet20003559118Open DOISearch in Google Scholar
de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol. 1995; 10:19-23.10.1097/00004850-199512004-000048930006de BoerTThe effects of mirtazapine on central noradrenergic and serotonergic neurotransmissionInt Clin Psychopharmacol1995101923Open DOISearch in Google Scholar
Wolfe F, Smythe HA, Yanus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter Criteria Committee. Arthritis Rheum. 1990; 33:160-72.10.1002/art.17803302032306288Wolfe FSmytheHAYanusMBBennettRMBombardier CGoldenbergDLet alThe American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter Criteria CommitteeArthritis Rheum19903316072Open DOISearch in Google Scholar
Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimeters? Pain. 1997; 72:95-7.10.1016/S0304-3959(97)00005-5CollinsSLMooreRAMcQuayHJThe visual analogue pain intensity scale: what is moderate pain in millimeters?Pain199772957Open DOISearch in Google Scholar
Leurmarnkul W and Meetam P. Properties testing of the retranslated SF-36 (Thai version). Thai J Pharm Sci. 2005; 29:69-88.LeurmarnkulWMeetamPProperties testing of the retranslated SF -36 (Thai version)Thai J Pharm Sci2005296988Search in Google Scholar
Jones GT, Atzeni F, Beasley M, Flüβ E, Sarzi-Puttini P. Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheum. 2015; 2: 568-75.JonesGTAtzeni FBeasley MFlüβ ESarzi-PuttiniPMacfarlaneGJThe prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteriaArthritis Rheum201525687510.1002/art.38905Search in Google Scholar
Verbunt JA, Pernot DHFM, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual life outcomes. 2008; 6:1-8.VerbuntJAPernotDHFMSmeetsRJDisability and quality of life in patients with fibromyalgiaHealth Qual life outcomes200861810.1186/1477-7525-6-8Search in Google Scholar
Birtane M, Uzunca K, Ta°tekin N, Tuna H. The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. Clin Rheumatol. 2007; 26:679-84.10.1007/s10067-006-0359-216897118Birtane MUzunca KTa°tekinNTunaHThe evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health SurveyClin Rheumatol20072667984Open DOISearch in Google Scholar
Unruh A. Gender variations in clinical pain experience. Pain. 1996; 65:123-67.882650310.1016/0304-3959(95)00214-6UnruhAGender variations in clinical pain experiencePain19966512367Search in Google Scholar
Berkley K. Sex differences in pain. Behav Brain Sci. 1997; 20:371-80.10097000BerkleyKSex differences in painBehav Brain Sci1997203718010.1017/S0140525X97221485Search in Google Scholar
Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, et al. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr Med Res Opin. 2006; 22: 257-64.1646659710.1185/030079906X80486Freynhagen RMuth-Selbach ULipfert PStevensMFZacharowski KTölleTRet alThe effect of mirtazapine in patients with chronic pain and concomitant depressionCurr Med Res Opin20062225764Search in Google Scholar
Yodchai K, Dunning T, Savage S, Hutchinson AM, Oumtanee A. How do Thai patients receiving haemodialysis cope with pain? J Ren Care. 2014; 40: 205-15.10.1111/jorc.12073Yodchai KDunning TSavage SHutchinsonAMOumtaneeAHow do Thai patients receiving haemodialysis cope with pain?J Ren Care20144020515Open DOISearch in Google Scholar
Martin MY, Bradley LA, Alexander RW, Alarcon GS, Triana-Alexander M, Aaron LA, et al. Coping strategies predict disability in patients with primary fibromyalgia. Pain. 1996; 68:45-53.925199710.1016/S0304-3959(96)03179-XMartinMYBradleyLAAlexanderRWAlarconGSTriana-Alexander MAaronLAet alCoping strategies predict disability in patients with primary fibromyalgiaPain1996684553Search in Google Scholar
Nicassio PM, Schoenfeld-Smith K, Radojevic V, Schuman C. Pain coping mechanisms in fibromyalgia: relationship to pain and functional outcome. J Rheumatol. 1995; 22:1552-8.7473482NicassioPMSchoenfeld-Smith KRadojevic VSchumanCPain coping mechanisms in fibromyalgia: relationship to pain and functional outcomeJ Rheumatol19952215528Search in Google Scholar
Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symp Man. 2002; 23: 442-7.10.1016/S0885-3924(02)00381-0TheobaldDEKirshKLHoltsclaw EDonaghy KPassikSDAn open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptomsJ Pain Symp Man2002234427Open DOISearch in Google Scholar
